Filtered By:
Source: Medscape Medical News Headlines
This page shows you your search results in order of date. This is page number 14.
Order by Relevance | Date
Total 315 results found since Jan 2013.
Racial Disparities in Outpatient Neurologic Care Racial Disparities in Outpatient Neurologic Care
Blacks and Hispanics with Parkinson ' s, stroke, and other neurologic conditions are less likely to see a neurologist in the office than their white peers.Medscape Medical News
Source: Medscape Medical News Headlines - May 29, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Anesthesia as Safe as Conscious Sedation in Stroke Thrombectomy Anesthesia as Safe as Conscious Sedation in Stroke Thrombectomy
Two new randomized studies have provided reassurance on the safety of general anesthesia for patients undergoing endovascular therapy for acute stroke.Medscape Medical News
Source: Medscape Medical News Headlines - May 24, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Probucol Reduces Events in Stroke Patients at Risk for ICH Probucol Reduces Events in Stroke Patients at Risk for ICH
The novel lipid-lowering/antioxidant drug may offer a potential new secondary prevention option in these patients at risk for both major forms of stroke, PICASSO investigators suggest.Medscape Medical News
Source: Medscape Medical News Headlines - May 19, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
NOR-TEST: Tenecteplase Similar to Alteplase in Stroke NOR-TEST: Tenecteplase Similar to Alteplase in Stroke
The newer thrombolytic given as a bolus dose showed functional and safety outcomes similar to those of alteplase infusion in the NOR-TEST trial.Medscape Medical News
Source: Medscape Medical News Headlines - May 19, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
DAWN: Thrombectomy Effective Up to 24 Hours After Stroke DAWN: Thrombectomy Effective Up to 24 Hours After Stroke
The DAWN trial showed impressive results in selected stroke patients presenting late and should substantially expand the population eligible for endovascular treatment.Medscape Medical News
Source: Medscape Medical News Headlines - May 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Finally, Success Reducing Recurrent Stroke With PFO Closure Finally, Success Reducing Recurrent Stroke With PFO Closure
Two new clinical trials showing a reduction in recurrent strokes with the closure of a patent foramen ovale (PFO) look set to change clinical practice.Medscape Medical News
Source: Medscape Medical News Headlines - May 17, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
REVEAL-AF: Silent AF Common in Patients at Risk for AF, Stroke REVEAL-AF: Silent AF Common in Patients at Risk for AF, Stroke
"The atrium doesn ' t care whether you have palpitations, dizziness, or no symptoms," notes a researcher; preventive anticoagulation is probably as important in silent AF AS in recognized AF, he said.Heartwire from Medscape
Source: Medscape Medical News Headlines - May 16, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
BRAVO 3 TAVR and AF: Stroke Risk, Discharge Meds Differ BRAVO 3 TAVR and AF: Stroke Risk, Discharge Meds Differ
In the BRAVO-3 trial of patients who had transfemoral TAVR with procedural bivalirudin or heparin, patients with new-onset AF had a much greater stroke risk; there was also an"incredible" variation in discharge meds.Heartwire from Medscape
Source: Medscape Medical News Headlines - May 12, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Beta2-Microglobulin: A Biomarker for Stroke Risk? Beta2-Microglobulin: A Biomarker for Stroke Risk?
Raised levels of the protein were associated with an increased risk for ischemic stroke among women in a new study.Medscape Medical News
Source: Medscape Medical News Headlines - May 11, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Costs for Neurologic Diseases Soar Costs for Neurologic Diseases Soar
Dementia, stroke, and other neurologic diseases collectively cost some $800 billion annually, and experts warn that the economic impact will worsen without increased research funding.Medscape Medical News
Source: Medscape Medical News Headlines - April 13, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Stroke Survivors May Stop Secondary Prevention Medications Stroke Survivors May Stop Secondary Prevention Medications
Stroke survivors may grow frustrated with doctors ' advice and ultimately stop taking medicines that could prevent a second stroke, suggests a new analysis from the UK.Reuters Health Information
Source: Medscape Medical News Headlines - April 11, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation Fewer Bleeds on Uninterrupted Dabigatran vs Warfarin in AF Ablation
"Now we have high-quality data showing that if you perform this procedure on uninterrupted dabigatran, the risk of stroke is extremely low," said a researcher about the randomized RE-CIRCUIT trial.Heartwire from Medscape
Source: Medscape Medical News Headlines - March 28, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Secondary-Prevention Data Strong for Fish Oil Caps: AHA Advisory Secondary-Prevention Data Strong for Fish Oil Caps: AHA Advisory
But there ' s not enough evidence to recommend them for primary prevention of cardiovascular disease, or even for secondary stroke prevention, according to an advisory updating 15 years of evidence.Heartwire from Medscape
Source: Medscape Medical News Headlines - March 17, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
Intensive Speech Therapy Helps Months After Stroke Intensive Speech Therapy Helps Months After Stroke
Reuters Health Information
Source: Medscape Medical News Headlines - March 9, 2017 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news
EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation EMA Recommends EU Marketing of Edoxaban in Atrial Fibrillation
The recommendation is for prevention of stroke and systemic embolism in atrial fibrillation and for the treatment and prevention of DVT and PE.International Approvals
Source: Medscape Medical News Headlines - February 24, 2017 Category: Consumer Health News Tags: Cardiology News Source Type: news
